Abstract: The disclosure provides a compound, an organic electroluminescent device and a display device. Wherein, the compound has a structure as shown in Formula I. The introduction of a substituent Ar2 at the 1-position of naphthalene ring can not only adjust the adjacent steric hindrance size, but also effectively regulate the distortion degree of a molecule so as to reduce the crystallinity of the molecule. Secondly, an arylamino group is introduced at the 2-position, and the introduction of a trisubstituted structure on the arylamino group can effectively regulate the stereostructure of the molecule, improve the packing density of the molecule, so that the materials designed can meet the requirements of devices for materials. The compound of the disclosure can improve the luminous efficiency, reduce the starting voltage and prolong the service life of the device when it is applied to the organic electroluminescent device.

Abstract: Provided is a high-affinity T cell receptor (TCR) that recognizes SSX2, wherein the TCR has the property of binding to a KASEKIFYV (SEQ ID NO: 29)-HLA A0201 complex, and the binding affinity of the TCR to the KASEKIFYV (SEQ ID NO: 29)-HLA A0201 complex is at least twice the binding affinity of a wild-type TCR to the KASEKIFYV (SEQ ID NO: 29)-HLA A0201 complex. Also provided is a fusion molecule of such a TCR with a therapeutic agent. Such a TCR can be used alone or in combination with a therapeutic agent to target tumor cells presenting the KASEKIFYV (SEQ ID NO: 29)-HLA A0201 complex.

Abstract: Described herein are additives for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high capacity retention during battery cycling at high temperatures. In some embodiments, a high voltage electrolyte includes a base electrolyte and one or more vinylsilane or fluorosilane additives, which impart these desirable performance characteristics.

Abstract: Disclosed are a diglycosylated benzophenoxazine photosensitizer, and a preparation method and use thereof. The present invention greatly improves the enriched concentration of the photosensitizer in tumor cells by taking full advantage of the enhanced uptake and enhanced glycolysis of carbohydrates by tumor cells and the glycosylation of a selenium-containing benzophenoxazine compound, thereby improving the targeting of a diglycosylated benzophenoxazine photosensitizer involved in the present invention in the treatment of cutaneous tumors and also significantly decreasing the toxic and side effects of the photodynamic therapy. The present invention can efficiently and rapidly inhibit the proliferation of cells of cutaneous squamous cell carcinoma and essentially cause no damage to normal cells.

Abstract: A compound, an organic electroluminescent device containing the compound, and an application thereof. The compound has a structure shown in (I).

Abstract: Described herein are additives for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high capacity retention during battery cycling at high temperatures. In some embodiments, a high voltage electrolyte includes a base electrolyte and one or more vinylsilane or fluorosilane additives, which impart these desirable performance characteristics.

Abstract: A lithium ion battery includes a cathode, an anode, and an electrolyte. The electrolyte includes a lithium salt, a solvent, a first additive, and a second additive. The first additive contributes to formation of a cathode solid electrolyte interface (SEI) on a surface of the cathode. The second additive contributes to formation of an anode SEI on a surface of the anode.

Abstract: Described herein are additives for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high capacity retention during battery cycling at high temperatures. In some embodiments, a high voltage electrolyte includes a base electrolyte and one or more polymer additives, which impart these desirable performance characteristics. The polymer additives can be homopolymers or copolymers.

Abstract: Described herein are additives for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high capacity retention during battery cycling at high temperatures. In some embodiments, a high temperature electrolyte includes a base electrolyte and one or more polymer additives, which impart these desirable performance characteristics.

Abstract: Provided is a T cell receptor (TCR) having a feature of binding to a VLDGLDVLL-HLA A2 complex. The binding affinity of the TCR to the VLDGLDVLL-HLA-A0201 complex is at least 2 times of the binding affinity of a wild-type TCR to the VLDGLDVLL-HLA-A0201 complex. Also provided is a fusion molecule of the TCR and a therapeutic agent. The TCR can be used alone or in combination with a therapeutic agent to target a tumor cell presenting the VLDGLDVLL-HLA-A0201 complex.

Abstract: A non-aqueous redox flow battery includes a catholyte including a compound of formula (I): wherein E1 and E2 are independently O, S, S?O, S(?O)2, Se, NR11, or PR11; The compounds of the present technology are capable of undergoing a reversible two-electron transfer process, thus leading to high efficiency of molecular design and an increase in the overall energy density.

Abstract: Disclosed are a diglycosylated benzophenoxazine photosensitizer, and a preparation method and use thereof. The present invention greatly improves the enriched concentration of the photosensitizer in tumor cells by taking full advantage of the enhanced uptake and enhanced glycolysis of carbohydrates by tumor cells and the glycosylation of a selenium-containing benzophenoxazine compound, thereby improving the targeting of a diglycosylated benzophenoxazine photosensitizer involved in the present invention in the treatment of cutaneous tumors and also significantly decreasing the toxic and side effects of the photodynamic therapy. The present invention can efficiently and rapidly inhibit the proliferation of cells of cutaneous squamous cell carcinoma and essentially cause no damage to normal cells.

Abstract: Provided is a T cell receptor (TCR) having a property of binding to a SLLMWITQC-HLA A2 complex; and the binding affinity of the TCR to the SLLMWITQC-HLA A2 complex is at least twice that of a wild-type TCR to the SLLMWITQC-HLA A2 complex. Also provided is a fusion molecule of such a TCR with a therapeutic agent. Such a TCR can be used alone or in combination with a therapeutic agent so as to target tumour cells presenting the SLLMWITQC-HLA A2 complex.

Abstract: Described herein are additives for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high capacity retention during battery cycling at high temperatures. In some embodiments, a high voltage electrolyte includes a base electrolyte and one or more vinylsilane or fluorosilane additives, which impart these desirable performance characteristics.

Abstract: The present invention provides a non-aqueous redox flow battery comprising a negative electrode immersed in a non-aqueous liquid negative electrolyte, a positive electrode immersed in a non-aqueous liquid positive electrolyte, and a cation-permeable separator (e.g., a porous membrane, film, sheet, or panel) between the negative electrolyte from the positive electrolyte. During charging and discharging, the electrolytes are circulated over their respective electrodes. The electrolytes each comprise an electrolyte salt (e.g., a lithium or sodium salt), a transition-metal free redox reactant, and optionally an electrochemically stable organic solvent. The redox reactant of the positive electrolyte is a dialkoxybenzene compound, and the redox reactant of the negative electrolyte is a viologen compound or a dipyridyl ketone.

Abstract: The present invention provides an aqueous redox flow battery comprising a negative electrode immersed in an aqueous liquid negative electrolyte, a positive electrode immersed in an aqueous liquid positive electrolyte, and a cation-permeable separator (e.g., a porous membrane, film, sheet, or panel) between the negative electrolyte from the positive electrolyte. During charging and discharging, the electrolytes are circulated over their respective electrodes. The electrolytes each comprise an electrolyte salt (e.g., a lithium or sodium salt), a redox reactant. The negative redox reactant comprises a pyridinium compound of Formula (I) as described in the specification.

Abstract: Described herein are additives for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high capacity retention during battery cycling at high temperatures. In some embodiments, a high temperature electrolyte includes a base electrolyte and one or more polymer additives, which impart these desirable performance characteristics.

Abstract: Described herein are additives for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high capacity retention during battery cycling at high temperatures. In some embodiments, a high voltage electrolyte includes a base electrolyte and one or more polymer additives, which impart these desirable performance characteristics. The polymer additives can be homopolymers or copolymers.

Abstract: Described herein are additives for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high capacity retention during battery cycling at high temperatures. In some embodiments, a high temperature electrolyte includes a base electrolyte and one or more polymer additives, which impart these desirable performance characteristics.